Collaboration & Cooperation
AMMF is an active member of:
- Cholangiocarcinoma-UK
- NCRI (National Cancer Research Institute) Upper GI Cancers Hepatobiliary Group
- NCRI BTC Trial Management Group
- Global Cholangiocarcinoma Alliance
- European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- Cancer52
- ECPC Working Group on Rare Cancers
- The International Biliary Tract Cancer Collaborators Group
AMMF values its collaborative links with like-minded organisations and research centres across the UK, Europe and globally:
Organisations:
- BASL (British Association for the Study of the Liver)
- The British Liver Trust
- British Society of Gastroenterology (BSG)
- Cancer Research UK
- Macmillan
- Rare Disease UK
- Rare Disease Europe (Eurordis)
- ESMO (European Society of Medical Oncology)
- European Cancer Patient Coalition (ECPC)
- The European Organisation for Research and Treatment of Cancer (EORTC)
- ERN (European Reference Networks)
- Cholangiocarcinoma Foundation of Thailand
- CASCAP
- Cholangiocarcinoma Australasia
- The Cholangiocarcinoma Foundation
- TargetCancer Foundation
- APiC (Associazione Pazienti Italiani di Colangiocarcinoma)
- ELPA (European Liver Patients’ Association)
Research Centres:
- Imperial College London
- University College London
- The Institute of Hepatology London
- University of Birmingham
- University of Cambridge
- University of Edinburgh
- Institute of Genetics & Molecular Medicine (The University of Edinburgh)
- University of Nottingham
- University of East Anglia
- University of Manchester
- University of Liverpool
- University of Oxford
- University of Leeds
- Cardiff University
- Universities of Madrid, Navarra and Pamplona, Spain
- John Hopkins University, USA
For more information on the research AMMF is supporting, click here.
Corporate Supporters:
We are very grateful for the support given by our generous corporate supporters, especially: